Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy variable 3-53 is a gene segment that encodes the variable region of the heavy chain of immunoglobulins (antibodies) in humans. The variable domain is responsible for antigen recognition, forming part of the antigen-binding site of immunoglobulin molecules. IGHV3-53 is a source of genetic diversity in the adaptive immune response and is especially notable as a common germline gene segment found in potent neutralizing antibodies against certain viral infections. It is not a classical therapeutic target like a receptor or enzyme, but it is essential for the specificity of antibody-based immune responses.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy variable 3-53 (IGHV3-53).